SUCCESS A und die zwei aktuell rekrutierenden Studien SUCCESS B und SUCCESS C stehen in der Nachfolge der großen und erfolgreichen ADEBAR Studie. Diese Kontinuität in der Therapie des Mamma Karzinoms ermöglicht unserer Studiengruppe vielfältige Fragestellungen an einem großen Patientenkollektiv, mit einem bereits vor Jahren vorausschauend breit angelegtem Spektrum von wissenschaftlichen Daten, auf hohem Niveau zu erforschen.
Jährlich werden von den Mitgliedern unserer Studiengruppe eine große Zahl von Publikationen veröffentlicht und weltweit sehr viele Vorträge gehalten.
Diese Seite ermöglicht Ihnen einen kleinen Einblick in die aktuellen wissenschaftlichen Veröffentlichungen die aus den Daten der ADEBAR und SUCCESS Studien hervorgehen.
Bitte beachten Sie jedoch, daß bei allen Publikationen die gesamten Rechte bei den Urhebern liegen und die Ergebnisse sowie deren grafische Aufarbeitung keinesfalls ohne Zustimmung verwendet werden darf.
Jahr 2014 | Internet
|
Thema |
Publikation |
Poster
|
Presentation |
37nd Annual San Antonio Breast Cancer Symposium | www.sabcs.org/ |
Prevalence of circulating tumor cells (CTCs) after five years of zoledronate treatment in the adjuvant SUCCESS-A study | |||
Prognostic relevance of Circulating Tumor Cells across different molecular subgroupsin the adjuvant SUCCESS-A Study | |||||
Detection of EMT, anoikis and stem cell markers in metastatic breast cancer patients under different lines of treatment | |||||
Journal of the National Cancer Institute |
Homepage JNCI | Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients | |||
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando | www.asco.org/ |
A Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Early Breast Cancer | |||
DETECT III/IV - two combined clinical trials based on the phenotype of circulating tumor cells (CTCs) | |||||
A Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Early Breast Cancer | |||||
Jahr 2013 | Internet
|
Thema |
Publikation |
Poster
|
Presentation |
36nd Annual San Antonio Breast Cancer Symposium | www.sabcs.org/ |
EORTC 90091-10093 BIG 1-12 The Treat CTC trial – a new approach targeting circulating tumor cells (CTC) in early breast cancer (EBC) | |||
A Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Early Breast Cancer | |||||
Discordance of the ER- and HER2-Status on Disseminated Tumor Cells Compared to the Primary Tumor in Patients With Early Breast Cancer | |||||
The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC) | |||||
33. Jahrestagung der Deutschen Gesellschaft für Senologie – München | Neue Studienkonzepte |
||||
DETECT III | |||||
4ever | |||||
Senopedia Tools | |||||
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando | www.asco.org/ |
BioMarQ – a novel approach to automated HER2-analysis of circulating tumor cells (CTCs) | |||
Evaluation of prevalence, number and temporal changes of circulating tumor cells as assessed after 2 and 5 years of follow-up in patients with early breast cancer in SUCCESS A study | |||||
Prognostic value of HER2 on breast cancer survival | |||||
Persistence of HER2-overexpression on circulating tumor cells (CTC) in patients after systemic treatment for HER2-positive breast cancer – Follow up results of the German SUCCESS B trial | |||||
Jahr 2012 | Internet
|
Thema |
Publikation |
Poster
|
Presentation |
35nd Annual San Antonio Breast Cancer Symposium | www.sabcs.org/ |
DETECT III ‐ A multicenter, randomized, phase III study to compare standard therapy alone... | |||
Detection and characterization of circulating tumour cells in blood and disseminated tumour cells... | |||||
Circulating Tumor Cells (CTC) may Express HER2/neu in Patients With Early HER2/neu Negative Breast Cancer... | |||||
Prognostic Value of Relative Change in Tumor Marker CA 27.29 in Early Stage Breast Cancer... | |||||
Prognostic factors in young breast cancer patients over time... | |||||
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando | www.asco.org/ |
HER2 expression on circulating tumor cells (CTC) in patients with early HER2-positive breast cancer: | |||
Chemotherapy-induced amenorrhea in premenopausal breast cancer patients... | |||||
Correlation of BMI with tumor stage in early breast cancer patients... | |||||
Correlation of high body mass index and circulating tumor cell positivity in patients with early-stage breast cancer | |||||
Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel vs. FEC120... | |||||
Jahr 2011 | Internet
|
Thema |
Publikation |
Poster
|
Presentation |
34nd Annual San Antonio Breast Cancer Symposium | www.sabcs.org/ |
Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel vs. FEC120 ... |
|||
DETECT III - A multicenter, randomized, phase III study... | |||||
Evaluation of the prevalence and prognostic significance of VEGF165b... | |||||
Influence of the Progesterone Receptor on the Prognosis... | |||||
Correlation of two analytical methods for circulating... | |||||
Anti-Müllerian hormone (AMH) levels in... | |||||
Quantitative and immunohistochemical detection of breast... | |||||
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando | www.asco.org/ |
Prognostic value of CA27.29 trend... | |||
Final Multivariate Analysis of Obesity and Disease... | |||||
Prognostic relevance of circulating tumor cells (CTCs)... | |||||
Interim analysis of toxicity evaluating the role of an anthracycline free... | |||||
Jahr 2010 | Internet
|
Thema |
Publikation |
Poster
|
Presentation |
33nd Annual San Antonio Breast Cancer Symposium | www.sabcs.org/ |
Circulating tumor cells (CTC) in peripheral blood... | |||
Prognostic Relevance of Circulating Tumor Cells... | |||||
Multivariate Analysis of Obesity and Disease Free Survival... | |||||
The prognostic relevance of serum CA 27.29 level... | |||||
Tumor Characteristics and Prognostic Factors in Nodal... | |||||
Journal Onkologie 03/2010 | www.journalonko.de |
Lifestyle und Mammakarzinom |
|||
Journal Onkologie 03/2010 | www.journalonko.de |
Neue Studienkonzepte am Beispiel Mammakarzinom: Die SUCCESS C-Studie |
|||
Jahr 2009 | Internet
|
Thema |
Poster
|
Presentation |
|
Gemeinsame Tagung der Bayerische Gesellschaft für Geburtshilfe und Frauenheilkunde (BGGF) und österreichische Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG) - Wien | Wertigkeit des Tumormarkes CA27-29 |
||||
32nd Annual San Antonio Breast Cancer Symposium | Sequential Treatment with Epirubicin... |
||||
Evaluation of CA27-29 as... |
|||||
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando | Effects of Granulocyte-colony... |
||||
Persistance of circulating tumor cells... |
|||||
EuropeanCanCerOrganisation | Effects of G-CSF on circulating... |
||||
7th International Symposium on Minimal Residual Cancer | Dose dependent effects of G-CSF... |
||||
Jahr 2008 | Internet
|
Poster
|
Presentation
|
||
31nd Annual San Antonio Breast Cancer Symposium | CA 27.29 as a tumour marker... |
||||
Toxicity analysis of a phase III study... |
|||||
ASCO Annual Meeting - The American Society of Clinical Oncology - Orlando | Prognostic relevance of circulating tumorcells in peripheral blood... |
||||
Jahr 2007 | Internet
|
Poster
|
Presentation
|
||
30nd Annual San Antonio Breast Cancer Symposium | Final toxicity analysis of... |
||||